Lead program Elafibranor is PPAR alpha/delta agonist in Ph 3 for NASH with data expected by YE 2019. Announced positive ph 2 PBC data in Dec 2018. Announced NASH biomarker diagnostic program; signed licensing agreement with LabCorp.
Anti-inflammatory, Metabolic Disorders
245, First Street, 18th Floor
Cambridge, MA 02142
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Upcoming Company Event Participation
Hamptons CEO Roundtable 2019
August 15, 2019
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by